Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2415
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab ; volume:13 ; number:1 ; day:20 ; month:8 ; year:2013 ; pages:1-8 ; date:12.2013
BMC ophthalmology ; 13, Heft 1 (20.8.2013), 1-8, 12.2013
- Creator
-
Sonoda, Shozo
- Contributor
-
Sakamoto, Taiji
Otsuka, Hiroki
Yoshinaga, Narimasa
Yamashita, Toshifumi
Ki-I, Yuya
Okubo, Akiko
Yamashita, Takehiro
Arimura, Noboru
SpringerLink (Online service)
- DOI
-
10.1186/1471-2415-13-43
- URN
-
urn:nbn:de:1111-201604146387
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sonoda, Shozo
- Sakamoto, Taiji
- Otsuka, Hiroki
- Yoshinaga, Narimasa
- Yamashita, Toshifumi
- Ki-I, Yuya
- Okubo, Akiko
- Yamashita, Takehiro
- Arimura, Noboru
- SpringerLink (Online service)
Other Objects (12)
Therapeutic effects of ranibizumab in patients with polypoidal choroidal vasculopathy
Intravitreal aflibercept for active polypoidal choroidal vasculopathy without active polyps
Innovator Versus Biosimilar Ranibizumab in Polypoidal Choroidal Vasculopathy: Real-World Evidence
Two-year outcomes of intravitreal conbercept therapy for polypoidal choroidal vasculopathy
Retinal pigment epithelial atrophy over polypoidal choroidal vasculopathy lesions during ranibizumab monotherapy
Polypoidal Choroidal Vasculopathy Associated with Optic Disc Coloboma
Comparison of the effects of photodynamic therapy, intravitreal ranibizumab and combination for polypoidal choroidal vasculopathy under 1 + PRN regimen
Comparison of 3-year outcomes of photodynamic therapy combined with intravitreal ranibizumab or aflibercept for polypoidal choroidal vasculopathy in a European cohort
Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration
One-year outcome of combination therapy with intravitreal aflibercept and photodynamic therapy for polypoidal choroidal vasculopathy
Intravitreal ranibizumab for choroidal neovascularization in a patient with angioid streaks and multiple evanescent white dots
Choroidal nevus and polypoidal vasculopathy: case series
Therapeutic effects of ranibizumab in patients with polypoidal choroidal vasculopathy
Intravitreal aflibercept for active polypoidal choroidal vasculopathy without active polyps
Innovator Versus Biosimilar Ranibizumab in Polypoidal Choroidal Vasculopathy: Real-World Evidence
Two-year outcomes of intravitreal conbercept therapy for polypoidal choroidal vasculopathy
Retinal pigment epithelial atrophy over polypoidal choroidal vasculopathy lesions during ranibizumab monotherapy
Polypoidal Choroidal Vasculopathy Associated with Optic Disc Coloboma
Comparison of the effects of photodynamic therapy, intravitreal ranibizumab and combination for polypoidal choroidal vasculopathy under 1 + PRN regimen
Comparison of 3-year outcomes of photodynamic therapy combined with intravitreal ranibizumab or aflibercept for polypoidal choroidal vasculopathy in a European cohort
Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration
One-year outcome of combination therapy with intravitreal aflibercept and photodynamic therapy for polypoidal choroidal vasculopathy
Intravitreal ranibizumab for choroidal neovascularization in a patient with angioid streaks and multiple evanescent white dots
Choroidal nevus and polypoidal vasculopathy: case series
Therapeutic effects of ranibizumab in patients with polypoidal choroidal vasculopathy
Intravitreal aflibercept for active polypoidal choroidal vasculopathy without active polyps
Innovator Versus Biosimilar Ranibizumab in Polypoidal Choroidal Vasculopathy: Real-World Evidence
Two-year outcomes of intravitreal conbercept therapy for polypoidal choroidal vasculopathy
Retinal pigment epithelial atrophy over polypoidal choroidal vasculopathy lesions during ranibizumab monotherapy
Polypoidal Choroidal Vasculopathy Associated with Optic Disc Coloboma
Comparison of the effects of photodynamic therapy, intravitreal ranibizumab and combination for polypoidal choroidal vasculopathy under 1 + PRN regimen
Comparison of 3-year outcomes of photodynamic therapy combined with intravitreal ranibizumab or aflibercept for polypoidal choroidal vasculopathy in a European cohort
Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration
One-year outcome of combination therapy with intravitreal aflibercept and photodynamic therapy for polypoidal choroidal vasculopathy
Intravitreal ranibizumab for choroidal neovascularization in a patient with angioid streaks and multiple evanescent white dots